Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Ricky LockettDO
Physical Medicine and Rehabilitation · Saint Petersburg, FL 33709
NPI: 1356410443
37
🟠 Elevated
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
22,546
Total Claims
$3.8M
Drug Cost
598
Beneficiaries
$6,375
Cost/Patient
Risk Score Breakdown 37/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,404 Physical Medicine and Rehabilitation providers
+84%
Opioid rate vs peers
37.3% vs 20.2% avg
+1300%
Cost per patient vs peers
$6,375 vs $455 avg
+261%
Brand preference vs peers
11.3% vs 3.1% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
Cost per patient is 1300% above the specialty average. Extreme cost outliers may indicate prescribing of unnecessarily expensive brand-name drugs or inappropriate drug utilization.
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
37.3%
Opioid Rate
8,405
Opioid Claims
$1.3M
Opioid Cost
40.3%
Long-Acting Rate
This provider's opioid prescribing rate of 37.3% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 2,557 claims · $2.1M
Generic: 19,989 claims · $1.7M
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Hcl | 457 | $549K |
| Methylnaltrexone Bromide | 190 | $454K |
| Dihydroergotamine Mesylate | 155 | $383K |
| Lactulose | 110 | $236K |
| Oxycodone Myristate | 180 | $197K |
| Naproxen | 269 | $189K |
| Triamcinolone Acetonide | 122 | $142K |
| Oxycodone Hcl | 2,882 | $121K |
| Lidocaine | 464 | $111K |
| Rimegepant Sulfate | 67 | $101K |
| Naloxegol Oxalate | 156 | $78K |
| Morphine Sulfate | 1,531 | $74K |
| Oxycodone Hcl | 53 | $73K |
| Fentanyl | 391 | $65K |
| Lipase/Protease/Amylase | 20 | $56K |
Prescribing Profile
121
Unique Drugs
37.0
Anomaly Score
Patient Profile
64
Avg Age
59%
Female
1.97
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About